NEW YORK – It's been 10 years since the US Food and Drug Administration approved the first indication for Merck's Keytruda (pembrolizumab), and over that time, the immunotherapy has racked up 41 ...

The pace of mergers and acquisitions remained strong this week, with Kraft Heinz, Engineering software firm Altair, and Spirit Airlines grabbing headlines. Here's a list of other key deals this week: ...

“Contact dermatitis and stasis dermatitis are often misdiagnosed as cellulitis,” said Merck Manual Professional Version, reviewed by Dr. Wingfield E. Rehmus. A vascular ultrasound scan may be ...

Alberta Premier Danielle Smith says her government will review professional regulatory bodies ... to undergo training after complaints about his online comments. Jordan Peterson agrees to social ...

Oct 23 (Reuters) - Merck (MRK.N), opens new tab has acquired ... Reuters provides business, financial, national and international news to professionals via desktop terminals, the world's media ...

Merck & Co. is putting down $30 million upfront to buy Yale spinout Modifi Biosciences, a deal that includes a preclinical asset designed to take on the tough-to-treat brain cancer glioblastoma (GBM).

“We are honored to have Merck recognize the potential of our science, and as an oncology company, they are perfectly positioned to advance our innovations through clinical trials and ...

Today, a brief rundown of news from Merck & Co. and Roche, as well as updates from Sangamo Therapeutics, UCB and Catalent that you may have missed. MacroGenics, a developer of antibody medicines for ...

Merck’s MRK stock has declined 14.4% in the past six months against an increase of 9.7% for the Large Cap Pharmaceuticals industry. The stock has also underperformed the sector and the S&P 500 ...

The India Young Professionals Scheme visa allows Indian ... Candidates have 90 days from the date of the email to apply online, pay the visa application fee, including the immigration health ...

FOSTER CITY, Calif., & RAHWAY, N.J.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced new results ...